MRC1 and neoplasm: In order to observe the number and location of CD86+ and CD206+ macrophages in the tumor microenvironment under GSK126 and EPZ6438 treatment, we performed multiplex immunofluorescence (mIF) assays to observe F4/80, CD86, and CD206 with the Opal staining technique (Figure 5D).